Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-10-11
1996-07-30
Datlow, Philip I.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 31535
Patent
active
055411843
ABSTRACT:
A process for pharmaceutically treating a subject with S-(-)-3-morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazol e hemihydrate comprising preparing a composition containing the hemihydrate and topically applying the prepared composition to a surface of the subject.
REFERENCES:
patent: 5231095 (1993-07-01), Peralampi
CAS Registry Handbook, Number Section, 1984, p. 2480 RM, Registry No. 91524-16-2.
"Nio-Pyrenol," Chemical Abstracts, Chemical Substance Index, vol. 106, p. 6752 CS, Jan.-Jun. 1987.
Chemical Abstract, vol. 106, No. 2, Jan. 12, 1987, p. 277 Abstract 93 70 k, Boudi et al.
Ullmann's Encyclopedia of Industrial Chemistry, Fifth, Completely Revised Edition. (1987); vol. A8, Wolfgang Gerhartz et al. "Coronary Therapeutics To Display Technology," pp. 6-7.
Datlow Philip I.
Leiras Oy
LandOfFree
S-timolol hemihydrate treatment process does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with S-timolol hemihydrate treatment process, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and S-timolol hemihydrate treatment process will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1658720